O3 Holding GmbH - Publication Q2 2026 Interim Report
Published on 08/21/2026 at 15:15 | dgap.de| O3 Holding GmbH / Key word(s): Interim Report 21.08.2026 / 15:15 CET/CEST The issuer is solely responsible for the content of this announcement. BIOGGIO, SWITZERLAND, 21 August 2026 - O3 Holding GmbH (the Company), the holding company of KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, announces that the Q2 2026 Interim Report, due under the bond terms for The Company's FRN Senior Secured EUR 180,000,000 bond issue with ISIN NO0013360552 issued on 28 October 2024, has now been published on the Company’s website (www.kdpharmagroup.com/investor-relations). For further information please contact: investor.relations@kdpharmagroup.com 21.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | O3 Holding GmbH |
| Am Kraftwerk 6 | |
| 66450 Bexbach | |
| Germany | |
| Phone: | +49 (0)68 26 97 97 00 |
| E-mail: | investor.relations@kdpharmagroup.com |
| Internet: | https://kdpharmagroup.com |
| ISIN: | NO0013360552 |
| WKN: | A383V0 |
| Listed: | Regulated Unofficial Market in Frankfurt |
| LEI Code: | 529900Y5PUIBWBPAQV20 |
| EQS News ID: | 2387004 |
| End of News | EQS News Service |
| |
en | NO0013360552 | O3 HOLDING GMBH | boerse | 69981315 |
